“MEDEZE” Advances Preparations to Renovate the Premises and Visits the ATMPs Sandbox Project at the Bangrak Medical Center Building
Dr. Veerapol Khemarangsan Chief Executive Officer Chief Executive Officer of MEDEZE Group Public Company Limited (“MEDEZE”), together with Dr. Anek Muang-omklang, Deputy Director-General of the Department of Disease Control, led members of the media on a site visit to review the progress of the Advanced Therapy Medicinal Products Sandbox (ATMPs Sandbox) Project at the Bangrak Medical Center Building.
This project aims to advance the development of high-end medical innovations in support of precision preventive medicine. It is part of a collaborative effort in research and development of advanced medical technologies, with a focus on exploring innovative health solutions. The pilot phase centers on early-stage osteoarthritis treatment, dermatological conditions, and anti-aging interventions, with all research and testing conducted under strict regulatory oversight by government agencies to ensure the establishment of new standards for ATMP-based pharmaceutical and medical product development.
As a recognized expert in the analysis, isolation, cultivation, and cryopreservation of stem cells, MEDEZE also specializes in NK cell potential assessment, hair follicle cell banking, and robotic cell storage systems. The company continues to elevate its leadership in the biotech sector and stem cell banking in Thailand. MEDEZE is notably the only private enterprise selected to participate in this government-led initiative, reinforcing its commitment to public-private partnerships and its vision to position Thailand as a sustainable regional hub for advanced medical innovation.






IR Press Releases